# Study of V117957 in Overactive Bladder Syndrome

> **NCT06024642** · PHASE1 · COMPLETED · sponsor: **Imbrium Therapeutics** · enrollment: 51 (actual)

## Conditions studied

- Overactive Bladder Syndrome

## Interventions

- **DRUG:** V117957
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06024642
- **Lead sponsor:** Imbrium Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-30
- **Primary completion:** 2024-05-21
- **Final completion:** 2024-05-21
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024642, "Study of V117957 in Overactive Bladder Syndrome". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06024642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*